High-frequency oscillatory ventilation in pediatric respiratory failure: A multicenter experience

John H. Arnold, Nick G. Anas, Peter Luckett, Ira M. Cheifetz, Gerardo Reyes, Christopher J L Newth, Keith C. Kocis, Sabrina M. Heidemann, James H. Hanson, Thomas V. Brogan, Desmond J. Bohn

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Objective: The use of high-frequency oscillatory ventilation (HFOV) has increased dramatically in the management of respiratory failure in pediatric patients. We surveyed ten pediatric centers that frequently use high-frequency oscillation to describe current clinical practice and to examine factors related to improved outcomes. Design: Retrospective, observational questionnaire study. Setting: Ten tertiary care pediatric intensive care units. Patients: Two hundred ninety patients managed with HFOV between January 1997 and June 1998. Interventions: None. Measurements and Main Results: Patients were classified according to presence or absence of preexisting lung disease, symptomatic respiratory syncytial virus infection, or presence of cyanotic heart disease or residual right-to-left intracardiac shunt. In addition, patients for whom HFOV acutely failed were analyzed separately. Those patients with preexisting lung disease were significantly smaller, had a significantly higher incidence of pulmonary infection as the triggering etiology, and had a significantly greater duration of conventional ventilation before institution of HFOV compared with patients without preexisting lung disease. Stepwise logistic regression was used to predict mortality and the occurrence of chronic lung disease in survivors. In patients without preexisting lung disease, the model predicted a 70% probability of death when the oxygenation index (01) after 24 hrs was 28 in the immunocompromised patients and 64 in the patients without immunocompromise. In the immunocompromised patients, the model predicted a 90% probability of death when the 01 after 24 hrs was 58. In survivors without preexisting lung disease, the model predicted a 70% probability of developing chronic lung disease when the 01 at 24 hrs was 31 in the patients with sepsis syndrome and 50 in the patients without sepsis syndrome. In the patients with sepsis syndrome, the model predicted a 90% probability of developing chronic lung disease when the 01 at 24 hrs was 45. Conclusions: Given the number of centers involved and the size of the database, we feel that our results broadly reflect current practice in the use of HFOV in pediatric patients. These results may help in deciding which patients are most likely to benefit from aggressive intervention by using extracorporeal techniques and may help identify high-risk populations appropriate for prospective study of innovative modes of supporting gas exchange (e.g., partial liquid breathing or intratracheal pulmonary ventilation).

Original languageEnglish (US)
Pages (from-to)3913-3919
Number of pages7
JournalCritical Care Medicine
Volume28
Issue number12
StatePublished - 2000

Fingerprint

High-Frequency Ventilation
Respiratory Insufficiency
Pediatrics
Lung Diseases
Preexisting Condition Coverage
Systemic Inflammatory Response Syndrome
Chronic Disease
Immunocompromised Host
Survivors
Respiratory Syncytial Virus Infections
Pulmonary Ventilation
Pediatric Intensive Care Units
Tertiary Healthcare

Keywords

  • Adult respiratory distress syndrome
  • Artificial
  • High-frequency ventilation
  • Intermittent positive pressure ventilation
  • Mechanical ventilation
  • Pediatrics
  • Respira-tion disorders
  • Respiration
  • Respiratory distress syndrome
  • Respiratory insufficiency
  • Ventilators mechanical

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Arnold, J. H., Anas, N. G., Luckett, P., Cheifetz, I. M., Reyes, G., Newth, C. J. L., ... Bohn, D. J. (2000). High-frequency oscillatory ventilation in pediatric respiratory failure: A multicenter experience. Critical Care Medicine, 28(12), 3913-3919.

High-frequency oscillatory ventilation in pediatric respiratory failure : A multicenter experience. / Arnold, John H.; Anas, Nick G.; Luckett, Peter; Cheifetz, Ira M.; Reyes, Gerardo; Newth, Christopher J L; Kocis, Keith C.; Heidemann, Sabrina M.; Hanson, James H.; Brogan, Thomas V.; Bohn, Desmond J.

In: Critical Care Medicine, Vol. 28, No. 12, 2000, p. 3913-3919.

Research output: Contribution to journalArticle

Arnold, JH, Anas, NG, Luckett, P, Cheifetz, IM, Reyes, G, Newth, CJL, Kocis, KC, Heidemann, SM, Hanson, JH, Brogan, TV & Bohn, DJ 2000, 'High-frequency oscillatory ventilation in pediatric respiratory failure: A multicenter experience', Critical Care Medicine, vol. 28, no. 12, pp. 3913-3919.
Arnold, John H. ; Anas, Nick G. ; Luckett, Peter ; Cheifetz, Ira M. ; Reyes, Gerardo ; Newth, Christopher J L ; Kocis, Keith C. ; Heidemann, Sabrina M. ; Hanson, James H. ; Brogan, Thomas V. ; Bohn, Desmond J. / High-frequency oscillatory ventilation in pediatric respiratory failure : A multicenter experience. In: Critical Care Medicine. 2000 ; Vol. 28, No. 12. pp. 3913-3919.
@article{97f48c36e72a49378c9dc0ba78a8a040,
title = "High-frequency oscillatory ventilation in pediatric respiratory failure: A multicenter experience",
abstract = "Objective: The use of high-frequency oscillatory ventilation (HFOV) has increased dramatically in the management of respiratory failure in pediatric patients. We surveyed ten pediatric centers that frequently use high-frequency oscillation to describe current clinical practice and to examine factors related to improved outcomes. Design: Retrospective, observational questionnaire study. Setting: Ten tertiary care pediatric intensive care units. Patients: Two hundred ninety patients managed with HFOV between January 1997 and June 1998. Interventions: None. Measurements and Main Results: Patients were classified according to presence or absence of preexisting lung disease, symptomatic respiratory syncytial virus infection, or presence of cyanotic heart disease or residual right-to-left intracardiac shunt. In addition, patients for whom HFOV acutely failed were analyzed separately. Those patients with preexisting lung disease were significantly smaller, had a significantly higher incidence of pulmonary infection as the triggering etiology, and had a significantly greater duration of conventional ventilation before institution of HFOV compared with patients without preexisting lung disease. Stepwise logistic regression was used to predict mortality and the occurrence of chronic lung disease in survivors. In patients without preexisting lung disease, the model predicted a 70{\%} probability of death when the oxygenation index (01) after 24 hrs was 28 in the immunocompromised patients and 64 in the patients without immunocompromise. In the immunocompromised patients, the model predicted a 90{\%} probability of death when the 01 after 24 hrs was 58. In survivors without preexisting lung disease, the model predicted a 70{\%} probability of developing chronic lung disease when the 01 at 24 hrs was 31 in the patients with sepsis syndrome and 50 in the patients without sepsis syndrome. In the patients with sepsis syndrome, the model predicted a 90{\%} probability of developing chronic lung disease when the 01 at 24 hrs was 45. Conclusions: Given the number of centers involved and the size of the database, we feel that our results broadly reflect current practice in the use of HFOV in pediatric patients. These results may help in deciding which patients are most likely to benefit from aggressive intervention by using extracorporeal techniques and may help identify high-risk populations appropriate for prospective study of innovative modes of supporting gas exchange (e.g., partial liquid breathing or intratracheal pulmonary ventilation).",
keywords = "Adult respiratory distress syndrome, Artificial, High-frequency ventilation, Intermittent positive pressure ventilation, Mechanical ventilation, Pediatrics, Respira-tion disorders, Respiration, Respiratory distress syndrome, Respiratory insufficiency, Ventilators mechanical",
author = "Arnold, {John H.} and Anas, {Nick G.} and Peter Luckett and Cheifetz, {Ira M.} and Gerardo Reyes and Newth, {Christopher J L} and Kocis, {Keith C.} and Heidemann, {Sabrina M.} and Hanson, {James H.} and Brogan, {Thomas V.} and Bohn, {Desmond J.}",
year = "2000",
language = "English (US)",
volume = "28",
pages = "3913--3919",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - High-frequency oscillatory ventilation in pediatric respiratory failure

T2 - A multicenter experience

AU - Arnold, John H.

AU - Anas, Nick G.

AU - Luckett, Peter

AU - Cheifetz, Ira M.

AU - Reyes, Gerardo

AU - Newth, Christopher J L

AU - Kocis, Keith C.

AU - Heidemann, Sabrina M.

AU - Hanson, James H.

AU - Brogan, Thomas V.

AU - Bohn, Desmond J.

PY - 2000

Y1 - 2000

N2 - Objective: The use of high-frequency oscillatory ventilation (HFOV) has increased dramatically in the management of respiratory failure in pediatric patients. We surveyed ten pediatric centers that frequently use high-frequency oscillation to describe current clinical practice and to examine factors related to improved outcomes. Design: Retrospective, observational questionnaire study. Setting: Ten tertiary care pediatric intensive care units. Patients: Two hundred ninety patients managed with HFOV between January 1997 and June 1998. Interventions: None. Measurements and Main Results: Patients were classified according to presence or absence of preexisting lung disease, symptomatic respiratory syncytial virus infection, or presence of cyanotic heart disease or residual right-to-left intracardiac shunt. In addition, patients for whom HFOV acutely failed were analyzed separately. Those patients with preexisting lung disease were significantly smaller, had a significantly higher incidence of pulmonary infection as the triggering etiology, and had a significantly greater duration of conventional ventilation before institution of HFOV compared with patients without preexisting lung disease. Stepwise logistic regression was used to predict mortality and the occurrence of chronic lung disease in survivors. In patients without preexisting lung disease, the model predicted a 70% probability of death when the oxygenation index (01) after 24 hrs was 28 in the immunocompromised patients and 64 in the patients without immunocompromise. In the immunocompromised patients, the model predicted a 90% probability of death when the 01 after 24 hrs was 58. In survivors without preexisting lung disease, the model predicted a 70% probability of developing chronic lung disease when the 01 at 24 hrs was 31 in the patients with sepsis syndrome and 50 in the patients without sepsis syndrome. In the patients with sepsis syndrome, the model predicted a 90% probability of developing chronic lung disease when the 01 at 24 hrs was 45. Conclusions: Given the number of centers involved and the size of the database, we feel that our results broadly reflect current practice in the use of HFOV in pediatric patients. These results may help in deciding which patients are most likely to benefit from aggressive intervention by using extracorporeal techniques and may help identify high-risk populations appropriate for prospective study of innovative modes of supporting gas exchange (e.g., partial liquid breathing or intratracheal pulmonary ventilation).

AB - Objective: The use of high-frequency oscillatory ventilation (HFOV) has increased dramatically in the management of respiratory failure in pediatric patients. We surveyed ten pediatric centers that frequently use high-frequency oscillation to describe current clinical practice and to examine factors related to improved outcomes. Design: Retrospective, observational questionnaire study. Setting: Ten tertiary care pediatric intensive care units. Patients: Two hundred ninety patients managed with HFOV between January 1997 and June 1998. Interventions: None. Measurements and Main Results: Patients were classified according to presence or absence of preexisting lung disease, symptomatic respiratory syncytial virus infection, or presence of cyanotic heart disease or residual right-to-left intracardiac shunt. In addition, patients for whom HFOV acutely failed were analyzed separately. Those patients with preexisting lung disease were significantly smaller, had a significantly higher incidence of pulmonary infection as the triggering etiology, and had a significantly greater duration of conventional ventilation before institution of HFOV compared with patients without preexisting lung disease. Stepwise logistic regression was used to predict mortality and the occurrence of chronic lung disease in survivors. In patients without preexisting lung disease, the model predicted a 70% probability of death when the oxygenation index (01) after 24 hrs was 28 in the immunocompromised patients and 64 in the patients without immunocompromise. In the immunocompromised patients, the model predicted a 90% probability of death when the 01 after 24 hrs was 58. In survivors without preexisting lung disease, the model predicted a 70% probability of developing chronic lung disease when the 01 at 24 hrs was 31 in the patients with sepsis syndrome and 50 in the patients without sepsis syndrome. In the patients with sepsis syndrome, the model predicted a 90% probability of developing chronic lung disease when the 01 at 24 hrs was 45. Conclusions: Given the number of centers involved and the size of the database, we feel that our results broadly reflect current practice in the use of HFOV in pediatric patients. These results may help in deciding which patients are most likely to benefit from aggressive intervention by using extracorporeal techniques and may help identify high-risk populations appropriate for prospective study of innovative modes of supporting gas exchange (e.g., partial liquid breathing or intratracheal pulmonary ventilation).

KW - Adult respiratory distress syndrome

KW - Artificial

KW - High-frequency ventilation

KW - Intermittent positive pressure ventilation

KW - Mechanical ventilation

KW - Pediatrics

KW - Respira-tion disorders

KW - Respiration

KW - Respiratory distress syndrome

KW - Respiratory insufficiency

KW - Ventilators mechanical

UR - http://www.scopus.com/inward/record.url?scp=0034517848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034517848&partnerID=8YFLogxK

M3 - Article

C2 - 11153635

AN - SCOPUS:0034517848

VL - 28

SP - 3913

EP - 3919

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 12

ER -